Castle Biosciences Announces The Appointment Of Veracyte, Inc. CEO Bonnie H. Anderson To Its Board Of Directors

Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced the appointment of Bonnie H. Anderson to its Board of Directors. Ms. Anderson is the cofounder of Veracyte (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, where she serves as president and chief executive officer.

Help employers find you! Check out all the jobs and post your resume.

Back to news